- Home
- / GenMont Biotech
GenMont Biotech
Stock Price
NT$21
2024-10-29
Market Capitalization
NT$1.8 B
2024-10-29
Revenue
NT$401.2 M
FY, 2025
GenMont Biotech Summary
Company Summary
- Overview
- GenMont Biotech (also known as Jingyue Biotechnology, 景岳生物科技股份有限公司) is a biotechnology company that manufactures functional probiotic products and raw materials. It offers probiotic capsules, sachets, powders, troches, creams, tablets, etc.
- Type
- Public
- Status
- Active
- Founded
- 2000
- Website
- https://www.genmont.com.tw
- Cybersecurity rating
Table of Contents
GenMont Biotech Financials
Summary Financials
- Revenue (Q1, 2026)
- NT$89.2M
- Gross profit (Q1, 2026)
- NT$65.5M
- Net income (Q1, 2026)
- NT$1.8M
- Cash (Q1, 2026)
- NT$159.2M
- EBIT (Q1, 2026)
- NT$2.5M
- Enterprise value
- $1.8B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026